Steven Cohen Agenus Inc Transaction History

Point72 Asset Management, L.P.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$0.53 - $0.93 $9.61 Million - $16.9 Million	18,128,512 Added 151.26%	30,113,712 $17.5 Million
Q4 2023 Feb 14, 2024	SELL	$0.63 - $1.14 $3.55 Million - $6.42 Million	-5,630,611 Reduced 31.96%	11,985,200 $9.95 Million
Q3 2023 Nov 14, 2023	SELL	$1.12 - $1.88 $1,312 - $2,203	-1,172 Reduced 0.01%	17,615,811 $19.9 Million
Q2 2023 Aug 14, 2023	BUY	$1.31 - $2.04 $12.8 Million - $19.9 Million	9,776,083 Added 124.68%	17,616,983 $28.2 Million
Q1 2023 May 15, 2023	SELL	$1.45 - $2.95 $1.57 Million - $3.19 Million	-1,082,400 Reduced 12.13%	7,840,900 $11.9 Million
Q4 2022 Feb 14, 2023	BUY	$2.02 - $3.25 $1.11 Million - $1.79 Million	551,100 Added 6.58%	8,923,300 $21.4 Million
Q3 2022 Nov 14, 2022	BUY	$1.96 - $3.14 $14.8 Million - $23.8 Million	7,569,600 Added 943.13%	8,372,200 $17.2 Million
Q2 2022 Aug 15, 2022	BUY	$1.3 - $2.64 $1.04 Million - $2.12 Million	802,600 New	802,600 $1.56 Million
Q3 2021 Nov 15, 2021	SELL	$4.98 - $6.63 $10.2 Million - $13.6 Million	-2,045,800 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$2.56 - $5.49 $1.51 Million - $3.23 Million	-588,000 Reduced 22.33%	2,045,800 $11.2 Million
Q1 2021 May 17, 2021	BUY	$2.69 - $5.25 $7.08 Million - $13.8 Million	2,633,800 New	2,633,800 $7.16 Million
Q2 2018 Aug 14, 2018	SELL	$2.26 - $4.65 $7.84 Million - $16.1 Million	-3,469,613 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$3.51 - $6.04 $12.2 Million - $21 Million	3,469,613 New	3,469,613 $16.3 Million

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.